208 related articles for article (PubMed ID: 24892036)
1. Expression of Shelterin component POT1 is associated with decreased telomere length and immunity condition in humans with severe aplastic anemia.
Wang T; Mei SC; Fu R; Wang HQ; Shao ZH
J Immunol Res; 2014; 2014():439530. PubMed ID: 24892036
[TBL] [Abstract][Full Text] [Related]
2. [Telomere length and gene expression of shelterin in CD3(+) T cell of severe aplastic anemia patients].
Wang T; Fu R; Wang HQ; Qu W; Ruan EB; Wang GJ; Liu H; Wu YH; Wang XM; Song J; Xing LM; Guan J; Li LJ; Liu H; Liu CY; Wang YH; Jiang HJ; Ding K; Dong XF; Wang HL; Zhang T; Shao ZH
Zhonghua Yi Xue Za Zhi; 2013 May; 93(20):1533-6. PubMed ID: 24028717
[TBL] [Abstract][Full Text] [Related]
3. TRF2-tethered TIN2 can mediate telomere protection by TPP1/POT1.
Frescas D; de Lange T
Mol Cell Biol; 2014 Apr; 34(7):1349-62. PubMed ID: 24469404
[TBL] [Abstract][Full Text] [Related]
4. Coordinate regulation between expression levels of telomere-binding proteins and telomere length in breast carcinomas.
Butler KS; Hines WC; Heaphy CM; Griffith JK
Cancer Med; 2012 Oct; 1(2):165-75. PubMed ID: 23342266
[TBL] [Abstract][Full Text] [Related]
5. In vivo stoichiometry of shelterin components.
Takai KK; Hooper S; Blackwood S; Gandhi R; de Lange T
J Biol Chem; 2010 Jan; 285(2):1457-67. PubMed ID: 19864690
[TBL] [Abstract][Full Text] [Related]
6. Altered mRNA expression of telomere binding proteins (TPP1, POT1, RAP1, TRF1 and TRF2) in ulcerative colitis and Crohn's disease.
Da-Silva N; Arasaradnam R; Getliffe K; Sung E; Oo Y; Nwokolo C
Dig Liver Dis; 2010 Aug; 42(8):544-8. PubMed ID: 20061197
[TBL] [Abstract][Full Text] [Related]
7. TRF1 negotiates TTAGGG repeat-associated replication problems by recruiting the BLM helicase and the TPP1/POT1 repressor of ATR signaling.
Zimmermann M; Kibe T; Kabir S; de Lange T
Genes Dev; 2014 Nov; 28(22):2477-91. PubMed ID: 25344324
[TBL] [Abstract][Full Text] [Related]
8. Telomere length, TERT and shelterin complex proteins in hepatocellular carcinomas expressing "stemness"-related markers.
Kim H; Yoo JE; Cho JY; Oh BK; Yoon YS; Han HS; Lee HS; Jang JJ; Jeong SH; Kim JW; Park YN
J Hepatol; 2013 Oct; 59(4):746-52. PubMed ID: 23685049
[TBL] [Abstract][Full Text] [Related]
9. Abnormal mRNA Expression Levels of Telomere-Binding Proteins Represent Biomarkers in Myelodysplastic Syndromes: A Case-Control Study.
Liu B; Yan R; Zhang J; Wang B; Sun H; Cui X
Turk J Haematol; 2017 Aug; 34(3):200-206. PubMed ID: 28404540
[TBL] [Abstract][Full Text] [Related]
10. Telomere protection by TPP1/POT1 requires tethering to TIN2.
Takai KK; Kibe T; Donigian JR; Frescas D; de Lange T
Mol Cell; 2011 Nov; 44(4):647-59. PubMed ID: 22099311
[TBL] [Abstract][Full Text] [Related]
11. Analysis of telomere length variation and Shelterin complex subunit gene expression changes in ethanol-exposed human embryonic stem cells.
Moazzam M; Yim T; Kumaresan V; Henderson DC; Farrer LA; Zhang H
J Psychiatr Res; 2021 Nov; 143():543-549. PubMed ID: 33243459
[TBL] [Abstract][Full Text] [Related]
12. Changes in the expression of telomere maintenance genes might play a role in the pathogenesis of systemic lupus erythematosus.
Zhou JG; Qing YF; Yang QB; Xie WG; Zhao MC
Lupus; 2011 Jul; 20(8):820-8. PubMed ID: 21693493
[TBL] [Abstract][Full Text] [Related]
13. Developmental studies of Xenopus shelterin complexes: the message to reset telomere length is already present in the egg.
Vizlin-Hodzic D; Ryme J; Simonsson S; Simonsson T
FASEB J; 2009 Aug; 23(8):2587-94. PubMed ID: 19329760
[TBL] [Abstract][Full Text] [Related]
14. The evolution of metazoan shelterin.
Myler LR; Kinzig CG; Sasi NK; Zakusilo G; Cai SW; de Lange T
Genes Dev; 2021 Dec; 35(23-24):1625-1641. PubMed ID: 34764137
[TBL] [Abstract][Full Text] [Related]
15. Human Telomere Repeat Binding Factor TRF1 Replaces TRF2 Bound to Shelterin Core Hub TIN2 when TPP1 Is Absent.
Janovič T; Stojaspal M; Veverka P; Horáková D; Hofr C
J Mol Biol; 2019 Aug; 431(17):3289-3301. PubMed ID: 31158366
[TBL] [Abstract][Full Text] [Related]
16. Upregulation of shelterin and CST genes and longer telomeres are associated with unfavorable prognostic characteristics in prostate cancer.
Dos Santos GA; Viana NI; Pimenta R; de Camargo JA; Guimaraes VR; Romão P; Candido P; Dos Santos VG; Ghazarian V; Reis ST; Leite KRM; Srougi M
Cancer Genet; 2024 Jun; 284-285():20-29. PubMed ID: 38503134
[TBL] [Abstract][Full Text] [Related]
17. Binding of TPP1 protein to TIN2 protein is required for POT1a,b protein-mediated telomere protection.
Frescas D; de Lange T
J Biol Chem; 2014 Aug; 289(35):24180-7. PubMed ID: 25056954
[TBL] [Abstract][Full Text] [Related]
18. TRF2 promotes dynamic and stepwise looping of POT1 bound telomeric overhang.
Paul T; Liou W; Cai X; Opresko PL; Myong S
Nucleic Acids Res; 2021 Dec; 49(21):12377-12393. PubMed ID: 34850123
[TBL] [Abstract][Full Text] [Related]
19. A POT1 mutation implicates defective telomere end fill-in and telomere truncations in Coats plus.
Takai H; Jenkinson E; Kabir S; Babul-Hirji R; Najm-Tehrani N; Chitayat DA; Crow YJ; de Lange T
Genes Dev; 2016 Apr; 30(7):812-26. PubMed ID: 27013236
[TBL] [Abstract][Full Text] [Related]
20. POT1-TPP1 telomere length regulation and disease.
Aramburu T; Plucinsky S; Skordalakes E
Comput Struct Biotechnol J; 2020; 18():1939-1946. PubMed ID: 32774788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
